Stock DNLI DENALI THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Denali Therapeutics Inc.

Equities

DNLI

US24823R1059

Market Closed - Nasdaq
Other stock markets
 01:30:00 15/05/2024 am IST 		5-day change 1st Jan Change
19.75 USD +2.33% Intraday chart for Denali Therapeutics Inc. +17.21% -7.97%
08/05 Stifel Adjusts Price Target on Denali Therapeutics to $22 From $26, Maintains Hold Rating MT
08/05 Wedbush Adjusts Denali Therapeutics' Price Target to $30 From $31, Keeps Outperform Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
DENALI THERAPEUTICS INC. Stock Denali Therapeutics Inc.
 275.24Cr -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 11TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
BIONTECH SE Stock BioNTech SE
 2.23TCr -
ARGENX SE Stock argenx SE
 2.19TCr -
GENMAB A/S Stock Genmab A/S
 1.86TCr
  1. Stock Market
  2. Equities
  3. DNLI Stock
  4. Charts Denali Therapeutics Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW